HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma.

Abstract
CXCL14/BRAK (BRAK) is a secreted chemokine with anti-tumor activity, and its expression is suppressed in tumor cells. We previously reported the anti-tumor activity of BRAK in cell lines of head and neck squamous cell carcinoma (HNSCC) and the suppression of BRAK secretion in these cells. BRAK secretion in fibrosarcoma cells is restored by Fasudil, which is a Rho-kinase (ROCK) inhibitor. In this study, we examined the anti-tumor effect of BRAK by evaluating its gene expression and protein secretion in HNSCC cell lines. We found that BRAK mediated the suppressive effect of Fasudil against HNSCC cells. Tumor development in female BALB/cAJclnu/nu mice was suppressed by Fasudil. Also secretion of BRAK protein by tumor cell lines in vitro was significantly stimulated by Fasudil treatment. Similarly, the production of BRAK protein was significantly increased by the addition of Fasudil to cultured tumor cells. Furthermore Fasudil significantly increased BRAK gene expression at the mRNA level in HNSCC cell line. Inhibition of the RhoA/ROCK pathway by siRNAs significantly stimulated BRAK gene expression. These results show that the tumor-suppressive effect of Fasudil was mediated by BRAK, suggesting that Fasudil may therefore be useful for the treatment of HNSCC.
AuthorsChihiro Miyamoto, Yojiro Maehata, Kazuhiko Motohashi, Shigeyuki Ozawa, Takeharu Ikoma, Kouki Hidaka, Satoko Wada-Takahashi, Shun-Suke Takahashi, Fumihiko Yoshino, Ayaka Yoshida, Eiro Kubota, Ryu-Ichiro Hata, Masaichi-Chang-il Lee
JournalBiomedical research (Tokyo, Japan) (Biomed Res) Vol. 35 Issue 6 Pg. 381-8 ( 2014) ISSN: 1880-313X [Electronic] Japan
PMID25743344 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CXCL14 protein, human
  • Chemokines, CXC
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • rho-Associated Kinases
  • fasudil
Topics
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine (analogs & derivatives, pharmacology)
  • Animals
  • Carcinoma, Squamous Cell (genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Chemokines, CXC (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic (physiology)
  • Head and Neck Neoplasms (genetics, metabolism, pathology)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Neoplasms, Experimental (genetics, pathology)
  • Protein Kinase Inhibitors (pharmacology)
  • RNA, Messenger (genetics)
  • Real-Time Polymerase Chain Reaction
  • Squamous Cell Carcinoma of Head and Neck
  • rho-Associated Kinases (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: